Cancer chemotherapy reports. Part 3.
Guardado en:
| Autores Corporativos: | , , |
|---|---|
| Idioma: | Inglés |
| ISSN: | 0069-0139 |
| Publicado: |
Bethesda, Md.,
National Cancer Institute [etc.]; Washington, for sale by the Supt. of Docs., U. S. Govt. Print. Off.
Bethesda Md : National Cancer Institute |
| Colección: | DHEW publication ;
no. (NIH) 72-22, etc. |
| Materias: | |
| Títulos relacionados: | Fusionada con / Formas:
Cancer chemotherapy reports, Parts 1 and 2 Fusionada con / Formas: Cancer treatment reports Merged with Cancer chemotherapy reports, Parts 1 and 2 to form Cancer treatment reports. |
| LEADER | 02215cas a2200469 4500 | ||
|---|---|---|---|
| 001 | 7609154 | ||
| 003 | DNLM | ||
| 005 | 20130509060908.0 | ||
| 008 | 760815d19681975xxu x o0||| 0eng | ||
| 022 | |a 0069-0139 |l 0069-0139 | ||
| 030 | |a CCYPBY | ||
| 035 | |a (DNLM)C05260000(s) |z (DNLM)C10320000(s) | ||
| 035 | |a (OCoLC)01778692 | ||
| 040 | |a DNLM |c DNLM | ||
| 060 | 0 | 0 | |a W1 |b CA677G |
| 222 | 0 | |a Cancer chemotherapy reports. Part 3 | |
| 245 | 0 | 0 | |a Cancer chemotherapy reports. Part 3. |
| 260 | |a Bethesda, Md., |b National Cancer Institute [etc.]; Washington, for sale by the Supt. of Docs., U. S. Govt. Print. Off. | ||
| 260 | 3 | |a Bethesda Md : |b National Cancer Institute | |
| 300 | |a 6 v. |b ill. | ||
| 310 | |a Irregular | ||
| 362 | 0 | |a v. 1-6, no. 2; Dec. 1968-Oct. 1975. | |
| 490 | 1 | |a DHEW publication ; |v no. (NIH) 72-22, etc | |
| 500 | |a Issued May 1972-Oct. 1975 as DHEW publication no. (NIH) 72-22, etc. | ||
| 500 | |a Issue for Dec. 1968 has subtitle: Program information. | ||
| 500 | |a Sponsored May 1973-Oct. 1975 by the Division of Cancer Treatment | ||
| 510 | 1 | |9 4 |a Index medicus |x 0019-3879 |b v1n1,Dec. 1968-v6n2,Oct. 1975 | |
| 510 | 1 | |9 4 |a MEDLINE |b v1n1,Dec. 1968-v6n2,Oct. 1975 | |
| 510 | 1 | |9 4 |a PubMed |b v1n1,Dec. 1968-v6n2,Oct. 1975 | |
| 550 | |a Issued 1968-72 by the Program Analysis Branch; May 1973-July 1975 by Drug Research and Development, Division of Cancer Treatment. | ||
| 580 | |a Merged with Cancer chemotherapy reports, Parts 1 and 2 to form Cancer treatment reports. | ||
| 650 | 2 | |a Antineoplastic Agents |v Periodicals. | |
| 650 | 2 | |a Neoplasms |x drug therapy |v Periodicals. | |
| 710 | 2 | |a National Cancer Institute (U.S.). |b Division of Cancer Treatment. |b Drug Research and Development. | |
| 710 | 2 | |a National Cancer Institute (U.S.). |b Chemotherapy. |b Program Analysis Branch. | |
| 710 | 2 | |a National Cancer Institute (U.S.). |b Division of Cancer Treatment. | |
| 785 | 1 | 7 | |t Cancer chemotherapy reports, Parts 1 and 2 |
| 785 | 1 | 7 | |t Cancer treatment reports |
| 830 | 0 | |a DHEW publication ; |v no. (NIH) 72-22, etc. | |
| 910 | |a CCT | ||
| 999 | |c 58008 |d 58008 | ||
| 952 | |0 0 |1 0 |4 0 |7 0 |9 1946900 |a AS-HUCA |b AS-HUCA |h 1974-75. |o AS-HUCA-1946900JNL-0069-0139 |p AS-HUCA-1946900JNL-58008 |t 2663870 |y JNL | ||